Skip to content

Author

Hongjian Liu

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

USP36-mediated stabilization of NAT10 promotes osteosarcoma progression via ac4C-dependent KIF23 mRNA stabilization.

Osteosarcoma is an aggressive bone malignancy with a propensity for pulmonary metastasis, yet the molecular mechanisms linking protein homeostasis to epitranscriptomic regulation remain incompletely understood. Here, integrated transcriptomic, survival, protein-interaction, and CRISPR dependency analyses identified the...

Yan-Fei Wu, Li-Ping Ma, Zhao-Qi Chen et al. · 0 citations
Open access Jul 2026

Inhibition of ETS1/DRP1 axis attenuates intervertebral disc degeneration by suppressing excessive mitochondrial fission.

Findings revealed the ETS1/DRP1 axis as a novel pathogenic mechanism and a potential therapeutic target in IVDD and inhibition of ETS1 via AAV5-mediated RNA interference or targeting DRP1 with CRISPR/dCas9-KRAB system or Mdivi-1 alleviated mitochondrial dysfunction, cellular senescence, ECM degradation, and attenuated...

Peng-Fei Li, Yi-Chen Que, Shuhao Zhang et al. · 0 citations
Open access Aug 2026

DSCAM‐AS1 Facilitates Osteosarcoma Progression via Regulating miR‐211‐5p/PDCD6 Axis

Functional loss‐of‐function experiments demonstrated that silencing (knockdown) of DSCAM‐AS1 expression substantially diminished OS cell proliferation, migration, and invasion, while simultaneously promoting cellular apoptosis in vitro.

Qi Wang, Yun-Zheng Zhao, Long-Bao Shi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.